Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes

T Bugarcic, A Habtemariam, J Stepankova, P Heringova, J Kasparkova, RJ Deeth, RD Johnstone, A Prescimone, A Parkin, S Parsons, V Brabec, PJ Sadler

. 2008 ; 47 (24) : 11470-11486.

Language English Country United States

Document type Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc14047353

Grant support
NR8562 MZ0 CEP Register

The synthesis and characterization of ruthenium(II) arene complexes [(eta(6)-arene)Ru(N,N)Cl](0/+), where N,N = 2,2'-bipyridine (bipy), 2,2'-bipyridine-3,3'-diol (bipy(OH)(2)) or deprotonated 2,2'-bipyridine-3,3'-diol (bipy(OH)O) as N,N-chelating ligand, arene = benzene (bz), indan (ind), biphenyl (bip), p-terphenyl (p-terp), tetrahydronaphthalene (thn), tetrahydroanthracene (tha) or dihydroanthracene (dha), are reported, including the X-ray crystal structures of [(eta(6)-tha)Ru(bipy)Cl][PF(6)] (1), [(eta(6)-tha)Ru(bipy(OH)O)Cl] (2) and [(eta(6)-ind)Ru(bipy(OH)(2))Cl][PF(6)] (8). Complexes 1 and 2 exibit CH (arene)/pi (bipy or bipy(OH)O) interactions. In the X-ray structure of protonated complex 8, the pyridine rings are twisted (by 17.31 degrees). In aqueous solution (pH = 2-10), only deprotonated (bipy(OH)O) forms are present. Hydrolysis of the complexes was relatively fast in aqueous solution (t(1/2) = 4-15 min, 310 K). When the arene is biphenyl, initial aquation of the complexes is followed by partial arene loss. Complexes with arene = tha, thn, dha, ind and p-terp, and deprotonated bipyridinediol (bipy(OH)O) as chelating ligands, exhibited significant cytotoxicity toward A2780 human ovarian and A549 human lung cancer cells. Complexes [(eta(6)-bip)Ru(bipy(OH)O)Cl] (7) and [(eta(6)-bz)Ru(bipy(OH)O)Cl] (5) exhibited moderate cytotoxicity toward A2780 cells, but were inactive toward A549 cells. These activity data can be contrasted with those of the parent bipyridine complex [(eta(6)-tha)Ru(bipy)Cl][PF(6)] (1) which is inactive toward both A2780 ovarian and A549 lung cell lines. DFT calculations suggested that hydroxylation and methylation of the bipy ligand have little effect on the charge on Ru. The active complex [(eta(6)-tha)Ru(bipy(OH)O)Cl] (2) binds strongly to 9-ethyl-guanine (9-EtG). The X-ray crystal structure of the adduct [(eta(6)-tha)Ru(bipy(OH)O)(9-EtG-N7)][PF(6)] shows intramolecular CH (arene)/pi (bipy(OH)O) interactions and DFT calculations suggested that these are more stable than arene/9-EtG pi-pi interactions. However [(eta(6)-ind)Ru(bipy(OH)(2))Cl][PF(6)] (8) and [(eta(6)-ind)Ru(bipy)Cl][PF(6)] (16) bind only weakly to DNA. DNA may therefore not be the major target for complexes studied here.

000      
00000naa a2200000 a 4500
001      
bmc14047353
003      
CZ-PrNML
005      
20140310170143.0
007      
ta
008      
140225s2008 xxua f 000 0|eng||
009      
AR
035    __
$a (PubMed)19007206
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bugarcic, Tijana $u School of Chemistry, University of Edinburgh, West Mains Road, Edinburgh EH9 3JJ, UK.
245    14
$a The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes / $c T Bugarcic, A Habtemariam, J Stepankova, P Heringova, J Kasparkova, RJ Deeth, RD Johnstone, A Prescimone, A Parkin, S Parsons, V Brabec, PJ Sadler
520    9_
$a The synthesis and characterization of ruthenium(II) arene complexes [(eta(6)-arene)Ru(N,N)Cl](0/+), where N,N = 2,2'-bipyridine (bipy), 2,2'-bipyridine-3,3'-diol (bipy(OH)(2)) or deprotonated 2,2'-bipyridine-3,3'-diol (bipy(OH)O) as N,N-chelating ligand, arene = benzene (bz), indan (ind), biphenyl (bip), p-terphenyl (p-terp), tetrahydronaphthalene (thn), tetrahydroanthracene (tha) or dihydroanthracene (dha), are reported, including the X-ray crystal structures of [(eta(6)-tha)Ru(bipy)Cl][PF(6)] (1), [(eta(6)-tha)Ru(bipy(OH)O)Cl] (2) and [(eta(6)-ind)Ru(bipy(OH)(2))Cl][PF(6)] (8). Complexes 1 and 2 exibit CH (arene)/pi (bipy or bipy(OH)O) interactions. In the X-ray structure of protonated complex 8, the pyridine rings are twisted (by 17.31 degrees). In aqueous solution (pH = 2-10), only deprotonated (bipy(OH)O) forms are present. Hydrolysis of the complexes was relatively fast in aqueous solution (t(1/2) = 4-15 min, 310 K). When the arene is biphenyl, initial aquation of the complexes is followed by partial arene loss. Complexes with arene = tha, thn, dha, ind and p-terp, and deprotonated bipyridinediol (bipy(OH)O) as chelating ligands, exhibited significant cytotoxicity toward A2780 human ovarian and A549 human lung cancer cells. Complexes [(eta(6)-bip)Ru(bipy(OH)O)Cl] (7) and [(eta(6)-bz)Ru(bipy(OH)O)Cl] (5) exhibited moderate cytotoxicity toward A2780 cells, but were inactive toward A549 cells. These activity data can be contrasted with those of the parent bipyridine complex [(eta(6)-tha)Ru(bipy)Cl][PF(6)] (1) which is inactive toward both A2780 ovarian and A549 lung cell lines. DFT calculations suggested that hydroxylation and methylation of the bipy ligand have little effect on the charge on Ru. The active complex [(eta(6)-tha)Ru(bipy(OH)O)Cl] (2) binds strongly to 9-ethyl-guanine (9-EtG). The X-ray crystal structure of the adduct [(eta(6)-tha)Ru(bipy(OH)O)(9-EtG-N7)][PF(6)] shows intramolecular CH (arene)/pi (bipy(OH)O) interactions and DFT calculations suggested that these are more stable than arene/9-EtG pi-pi interactions. However [(eta(6)-ind)Ru(bipy(OH)(2))Cl][PF(6)] (8) and [(eta(6)-ind)Ru(bipy)Cl][PF(6)] (16) bind only weakly to DNA. DNA may therefore not be the major target for complexes studied here.
536    __
$c Grant Number: (United States Howard Hughes Medical Institute)
590    __
$a bohemika - dle Pubmed
650    02
$a 2,2'-dipyridyl $x toxicita $7 D015082
650    02
$a kationty $x chemie $7 D002412
650    02
$a nádorové buněčné linie $x účinky léků $7 D045744
650    12
$a viabilita buněk $x účinky léků $7 D002470
650    02
$a krystalografie rentgenová $x metody $7 D018360
650    02
$a ženské pohlaví $7 D005260
650    02
$a lidé $7 D006801
650    02
$a vodíková vazba $7 D006860
650    02
$a hydrolýza $7 D006868
650    02
$a nádory plic $x patologie $7 D008175
650    02
$a magnetická rezonanční spektroskopie $x metody $7 D009682
650    02
$a molekulární modely $7 D008958
650    02
$a nádory vaječníků $x patologie $7 D010051
650    12
$a ruthenium $x toxicita $7 D012428
650    02
$a hmotnostní spektrometrie s elektrosprejovou ionizací $x metody $7 D021241
650    02
$a nádorové buňky kultivované $x patologie $x účinky léků $7 D014407
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Habtemariam, Abraha
700    1_
$a Štěpánková, Jana $7 xx0246599 $u Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Brno, Czech Republic
700    1_
$a Heringová, Pavla $7 _AN059902 $u Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Brno, Czech Republic
700    1_
$a Kašpárková, Jana, $d 1969- $7 xx0068609 $u Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Brno, Czech Republic
700    1_
$a Deeth, Robert J.
700    1_
$a Johnstone, Russell D.
700    1_
$a Prescimone, Alessandro
700    1_
$a Parkin, Andrew
700    1_
$a Parsons, Simon
700    1_
$a Brabec, Viktor, $d 1944- $7 jo20010087133 $u Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Brno, Czech Republic
700    1_
$a Sadler, Peter J.
773    0_
$t Inorganic Chemistry $g Roč. 47, č. 24 (2008), s. 11470-11486 $p Inorg Chem $x 0020-1669 $w MED00006467
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20140225101352 $b ABA008
991    __
$a 20140310170151 $b ABA008
999    __
$a ok $b bmc $g 1014320 $s 845897
BAS    __
$a 3
BMC    __
$a 2008 $b 47 $c 24 $d 11470-11486 $x MED00006467 $i 0020-1669 $m Inorganic chemistry $n Inorg Chem
GRA    __
$a NR8562 $p MZ0
LZP    __
$a NLK 2014-02/lpbo

Find record

Citation metrics

Archiving options